Join the adMare National Tx Accelerator

Eligibility and key areas of interest

Ventures working in the following areas will be considered high-priority:

• Therapeutics: broad range of disease indications (e.g., immunology, oncology, neurology, metabolomics) and categories (e.g., small molecules, biologics, cell and gene therapies).
• Artificial intelligence/machine learning platforms: supporting drug discovery or digital therapeutics.
• Enabling platforms: novel drug screen, discovery, and delivery platforms that can result in a novel drug-related IP. 

Ventures must be incorporated in Canada with ambitious growth plans, have at least 1 employee, have proprietary IP, and have raised pre-seed funding.

adMare is committed to equity, diversity, inclusion, and accessibility.

Application process and program duration

Applications for the adMare Tx Accelerator will be accepted on a rolling basis.

Successful applicants will be invited to present in person and undergo due diligence.

Selected ventures will have the opportunity to remain in the program for up to 24 months, based on progress in de-risking therapeutic technologies and achievement of milestones towards entering clinical trials and/or partnerships with pharma, and raising a Series A. 

Submission requirements

All interested Canadian ventures* are invited to apply by submitting a non-confidential proposal summary in pptx or PDF format, covering the following criteria:

• Problem
• Technology
• Supporting Data
• Intellectual Property
• Market Size
• Business and technology development plan
• Team

*Applications are encouraged from Indigenous people, women, people with disabilities, racialized people and 2SLGBTQIA+ people.

ALL SUBMISSIONS NOT CONFORMING TO THE APPLICATION FORMAT WILL BE DECLINED.

DOWNLOAD APPLICATION FORMAT [PPT]